Everolimus-eluting bioresorbable stent vs. durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction: results of the randomized ABSORB ST-segment elevation myocardial infarction—TROFI II trial

AIMS: Patients with ST-segment elevation myocardial infarction (STEMI) feature thrombus-rich lesions with large necrotic core, which are usually associated with delayed arterial healing and impaired stent-related outcomes. The use of bioresorbable vascular scaffolds (Absorb) has the potential to ove...

Descripción completa

Detalles Bibliográficos
Autores principales: Sabaté, Manel, Windecker, Stephan, Iñiguez, Andres, Okkels-Jensen, Lisette, Cequier, Angel, Brugaletta, Salvatore, Hofma, Sjoerd H., Räber, Lorenz, Christiansen, Evald Høi, Suttorp, Maarten, Pilgrim, Thomas, Anne van Es, Gerrit, Sotomi, Yohei, García-García, Hector M., Onuma, Yoshinobu, Serruys, Patrick W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
FASTTRACK CLINICAL RESEARCH
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4712350/
https://www.ncbi.nlm.nih.gov/pubmed/26405232
http://dx.doi.org/10.1093/eurheartj/ehv500

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4712350/
https://www.ncbi.nlm.nih.gov/pubmed/26405232
http://dx.doi.org/10.1093/eurheartj/ehv500

Ejemplares similares